| Shelly Aguilar, NP | |
|
1910 N Bush St, Santa Ana, CA 92706-2816 | |
| (714) 361-7950 | |
| Not Available |
| Full Name | Shelly Aguilar |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 1910 N Bush St, Santa Ana, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093239436 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 22945 (California) | Primary |
| Entity Name | Providence Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285890624 PECOS PAC ID: 8921993205 Enrollment ID: O20040216001346 |
News Archive
InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax's activities.
Navidea Biopharmaceuticals, Inc. today announced that the Banner Alzheimer's Institute, Phoenix, AZ, made two presentations of results from an AstraZeneca-sponsored study on the assessment of Navidea's late-stage radiopharmaceutical imaging candidate, AZD4694, at the 6th Annual Human Amyloid Imaging Meeting (HAI), in Miami, FL.
The U.S. House voted Tuesday to extend and expand the 10-year-old State Children's Health Insurance Program, called SCHIP. The Senate was expected to follow suit this week.
African Americans, who make up 13 percent of the U.S. population, are disproportionately affected by AIDS, accounting for nearly 49 percent of newly diagnosed HIV/AIDS cases nationwide.
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has retired a note, principal amount $160,000, in its continuing effort to reduce debt.
› Verified 3 days ago
| Entity Name | Telecare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720164882 PECOS PAC ID: 6901820380 Enrollment ID: O20070614000167 |
News Archive
InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax's activities.
Navidea Biopharmaceuticals, Inc. today announced that the Banner Alzheimer's Institute, Phoenix, AZ, made two presentations of results from an AstraZeneca-sponsored study on the assessment of Navidea's late-stage radiopharmaceutical imaging candidate, AZD4694, at the 6th Annual Human Amyloid Imaging Meeting (HAI), in Miami, FL.
The U.S. House voted Tuesday to extend and expand the 10-year-old State Children's Health Insurance Program, called SCHIP. The Senate was expected to follow suit this week.
African Americans, who make up 13 percent of the U.S. population, are disproportionately affected by AIDS, accounting for nearly 49 percent of newly diagnosed HIV/AIDS cases nationwide.
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has retired a note, principal amount $160,000, in its continuing effort to reduce debt.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelly Aguilar, NP 1910 N Bush St, Santa Ana, CA 92706-2816 Ph: (714) 361-7950 | Shelly Aguilar, NP 1910 N Bush St, Santa Ana, CA 92706-2816 Ph: (714) 361-7950 |
News Archive
InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax's activities.
Navidea Biopharmaceuticals, Inc. today announced that the Banner Alzheimer's Institute, Phoenix, AZ, made two presentations of results from an AstraZeneca-sponsored study on the assessment of Navidea's late-stage radiopharmaceutical imaging candidate, AZD4694, at the 6th Annual Human Amyloid Imaging Meeting (HAI), in Miami, FL.
The U.S. House voted Tuesday to extend and expand the 10-year-old State Children's Health Insurance Program, called SCHIP. The Senate was expected to follow suit this week.
African Americans, who make up 13 percent of the U.S. population, are disproportionately affected by AIDS, accounting for nearly 49 percent of newly diagnosed HIV/AIDS cases nationwide.
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has retired a note, principal amount $160,000, in its continuing effort to reduce debt.
› Verified 3 days ago
Mr. Gerardo M De Jesus, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 550 N Flower St, Santa Ana, CA 92703 Phone: 714-647-4170 | |
Miss Sonia Sedano, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 N Main St, Santa Ana, CA 92701 Phone: 888-499-9303 | |
Melissa A Medellin, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1002 N Fairview St, Santa Ana, CA 92703 Phone: 714-835-8501 | |
Elizabeth Branson, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2010 E 1st St # 100, Santa Ana, CA 92705 Phone: 909-800-3532 | |
Mr. Ramoncito Llorin Cimarra, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2001 E 4th St Ste 200, Santa Ana, CA 92705 Phone: 562-735-9541 | |
Kimberly A Umansky, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1751 E Garry Ave, Santa Ana, CA 92705 Phone: 877-896-7350 | |
Yingxuan Law, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1801 Park Court Pl Bldg H, Santa Ana, CA 92701 Phone: 206-817-2984 |